Selected article for: "disease epidemic and infectious disease epidemic"

Author: Corey M Peak; Rebecca Kahn; Yonatan H Grad; Lauren M Childs; Ruoran Li; Marc Lipsitch; Caroline O Buckee
Title: Modeling the Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19
  • Document date: 2020_3_8
  • ID: e2p46wa8_5
    Snippet: Briefly, individuals in a stochastic branching model progress through a susceptible-exposed-infectious-recovered (SEIR) disease process focused on the early stages of epidemic growth. Upon infection, individuals progress through a latent period before onset of infectiousness; during the duration of infectiousness, the relative infectiousness follows a triangular distribution. The time of symptom onset is measured as the difference between the inc.....
    Document: Briefly, individuals in a stochastic branching model progress through a susceptible-exposed-infectious-recovered (SEIR) disease process focused on the early stages of epidemic growth. Upon infection, individuals progress through a latent period before onset of infectiousness; during the duration of infectiousness, the relative infectiousness follows a triangular distribution. The time of symptom onset is measured as the difference between the incubation and latent periods, with negative values indicating presymptomatic infectiousness.

    Search related documents:
    Co phrase search for related documents
    • early stage and epidemic growth early stage: 1, 2, 3, 4, 5, 6, 7
    • early stage and infectiousness duration: 1
    • early stage and infectiousness onset: 1
    • early stage and latent incubation: 1
    • early stage and latent period: 1, 2, 3
    • early stage and negative value: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • early stage and stochastic branching model: 1, 2, 3, 4
    • early stage and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
    • early stage and symptom onset time: 1, 2, 3, 4, 5, 6, 7, 8
    • epidemic growth and infectiousness duration: 1, 2, 3
    • epidemic growth and infectiousness onset: 1, 2, 3, 4, 5, 6
    • epidemic growth and latent period: 1, 2, 3
    • epidemic growth and negative value: 1, 2, 3
    • epidemic growth and relative infectiousness: 1
    • epidemic growth and stochastic branching model: 1, 2
    • epidemic growth and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • epidemic growth and symptom onset time: 1, 2, 3, 4, 5
    • epidemic growth and triangular distribution: 1
    • infectiousness duration and latent incubation: 1, 2, 3, 4, 5, 6, 7, 8, 9